Skip to content

Author

Hai-Zhen Wang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

A CD44-regulating Multimodal Therapeutic Strategy for MAFLD-Associated Pancreatic Cancer Liver Metastasis.

Metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as a novel risk factor for pancreatic cancer, particularly early liver metastasis. However, the underlying mechanisms and effective therapeutic strategies remain largely unclear. Here, based on clinical databases, patient tissue samples, and singl...

Shun-Li Fu, Shuo Shan, Xiao-Ya Shi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.